top of page
ABOUT US
CAPITAL PARTNER
Validating the vision and propelling growth
As a Blackstone Life Sciences portfolio company, Uniquity Bio has access to ongoing capital resources to fund our clinical drug development, operations, and core capabilities. We operate independently under the Blackstone umbrella and enjoy a partnership that extends beyond capital investment to include scientific support and a shared commitment to excellence.
With Blackstone’s investment, our unique and sustainable business model maximizes the value creation of individual drug assets while fueling pipeline growth, operational agility, and clinical execution.
bottom of page